Necrotizing vasculitis--relapse despite cytotoxic therapy

M Gordon; R A Luqmani; D Adu; I Greaves; N Richards; J Michael; P Emery; P A Bacon

doi:10.1007/978-1-4757-9182-2_86

Necrotizing vasculitis--relapse despite cytotoxic therapy

Adv Exp Med Biol. 1993:336:477-81. doi: 10.1007/978-1-4757-9182-2_86.

Authors

M Gordon¹, R A Luqmani, D Adu, I Greaves, N Richards, J Michael, P Emery, P A Bacon

Affiliation

¹ Renal Research Laboratory, Queen Elizabeth Hospital, Birmingham.

PMID: 7905233
DOI: 10.1007/978-1-4757-9182-2_86

Abstract

The pattern of relapses is described in a consecutive series of 150 patients with vasculitis. Relapse occurred in 42 out of 124 patients who survived for more than 3 months.

MeSH terms

Adult
Aged
Arteritis / drug therapy
Arteritis / mortality
Azathioprine / therapeutic use
Cyclophosphamide / therapeutic use
Female
Granulomatosis with Polyangiitis / drug therapy
Granulomatosis with Polyangiitis / mortality
Humans
Male
Middle Aged
Polyarteritis Nodosa / drug therapy
Polyarteritis Nodosa / mortality
Prednisone / therapeutic use
Recurrence
Survival Rate
Vasculitis / drug therapy*
Vasculitis / mortality

Substances

Cyclophosphamide
Azathioprine
Prednisone